1. Home
  2. EPM vs LCTX Comparison

EPM vs LCTX Comparison

Compare EPM & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPM
  • LCTX
  • Stock Information
  • Founded
  • EPM 2003
  • LCTX 1990
  • Country
  • EPM United States
  • LCTX United States
  • Employees
  • EPM N/A
  • LCTX N/A
  • Industry
  • EPM Oil & Gas Production
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EPM Energy
  • LCTX Health Care
  • Exchange
  • EPM Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • EPM 171.8M
  • LCTX 165.6M
  • IPO Year
  • EPM 1996
  • LCTX N/A
  • Fundamental
  • Price
  • EPM $5.62
  • LCTX $0.89
  • Analyst Decision
  • EPM Strong Buy
  • LCTX Strong Buy
  • Analyst Count
  • EPM 1
  • LCTX 3
  • Target Price
  • EPM $8.25
  • LCTX $5.67
  • AVG Volume (30 Days)
  • EPM 321.5K
  • LCTX 318.6K
  • Earning Date
  • EPM 09-10-2024
  • LCTX 11-07-2024
  • Dividend Yield
  • EPM 8.90%
  • LCTX N/A
  • EPS Growth
  • EPM N/A
  • LCTX N/A
  • EPS
  • EPM 0.12
  • LCTX N/A
  • Revenue
  • EPM $85,877,000.00
  • LCTX $6,186,000.00
  • Revenue This Year
  • EPM N/A
  • LCTX N/A
  • Revenue Next Year
  • EPM $22.21
  • LCTX $119.00
  • P/E Ratio
  • EPM $44.92
  • LCTX N/A
  • Revenue Growth
  • EPM N/A
  • LCTX N/A
  • 52 Week Low
  • EPM $4.59
  • LCTX $0.77
  • 52 Week High
  • EPM $7.98
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • EPM 63.64
  • LCTX 48.24
  • Support Level
  • EPM $4.59
  • LCTX $0.83
  • Resistance Level
  • EPM $5.68
  • LCTX $0.94
  • Average True Range (ATR)
  • EPM 0.18
  • LCTX 0.05
  • MACD
  • EPM 0.08
  • LCTX 0.00
  • Stochastic Oscillator
  • EPM 90.83
  • LCTX 41.92

About EPM Evolution Petroleum Corporation Inc.

Evolution Petroleum Corp is an independent oil and gas company operating in the US. It is engaged primarily in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are primarily generated from its crude oil, natural gas and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana. The revenue generated by the company includes royalty, mineral and working interests.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: